US should look inward to tackle opioid crisis, Chinese officials say

In November, President Donald Trump blamed a "flood of cheap and deadly" fentanyl made in China for the deadliest drug epidemic in US history.

Ng Han Guan/AP Photo
Deng Ming, Deputy Secretary-General of the China National Narcotics Control Commission attends a press conference held in Beijing on Thursday, Dec. 28, 2017. A top Chinese drug enforcement official says the United States needs to do more to fight its opioid epidemic, including sharing more data and police intelligence with Chinese counterparts.

The United States should look within to cut down demand for opioids which are fueling its deadly drug crisis rather than stressing unsubstantiated claims that China is the major source of these chemicals, a top Chinese drug enforcement official said Thursday.

China and the US have worked to build a close working relationship to fight global flows of illicit synthetic drugs, but their collaboration remains fraught.

Yu Haibin of the China National Narcotics Control Commission told reporters there was little evidence showing China was the source of much of the chemicals used in the production of the powerful opioid fentanyl. President Donald Trump in November blamed a "flood of cheap and deadly" fentanyl made in China for the deadliest drug epidemic in US history.

"China doesn't deny that shipments to the US happen, but there isn't the proof to show how much — whether it's 20 percent or 80 percent," said Yu, adding that US authorities have only sent him information about six shipments from China in the past year.

In October 2016, the AP identified 12 Chinese companies willing to export carfentanil around the world for a few thousand dollars a kilogram (2.2. pounds), no questions asked. Carfentanil is 100 times more powerful than fentanyl and is legally used as an anesthetic for elephants and other large animals.

Yu urged the US to share more data and police intelligence with Chinese authorities and said rampant over-prescription of pain medication and lax cultural attitudes toward drugs had fueled massive demand for opioids in the US.

Insufficient drug education and the trend in some states of legalizing marijuana have hurt drug enforcement efforts, he said.

"As many states decriminalize marijuana, the public's attitudes and trends of thinking toward drugs will also have a bad effect" on the fight against hard drugs, Yu said.

Chinese officials have been eager to tout their collaboration with American counterparts on drug enforcement as a bright spot in the occasionally rocky relationship.

Though Beijing has said US assertions that China is the top source of fentanyls lack evidence, the two countries have deepened cooperation as the US opioid epidemic intensifies. Beijing already regulates fentanyl and a number of related compounds, even though they are not widely abused domestically.

Since 2016, China has arrested dozens of synthetic drug exporters, destroyed several illegal labs and seized tons of new psychoactive substances, according to the Office of the National Narcotics Control Committee.

Officials in Beijing said Thursday they busted a fentanyl factory in November and seized 4.7 kilograms (10.36 pounds) of the substance thanks to a tip-off from US Immigration and Customs about a major online purveyor named "Diana" that turned out to be a front for a 19-person drug ring scattered across China.

China wanted to work more closely with US law enforcement, as well as authorities in Mexico, a transshipment point, Yu said.

China has backed a successful US proposal this year to add several fentanyl precursors to a UN list of controlled substances. China has listed the two chemicals, NPP and 44-ANPP, under domestic drug laws, officials said.

More than 66,000 people in America died of drug overdoses in the year ending May 2017, a jump of 17.4 percent from the year before, according to provisional data from the Centers for Disease Control and Prevention. The CDC reports most cases of fentanyl overdose are linked to illicitly produced batches of the substance.

You've read  of  free articles. Subscribe to continue.

Dear Reader,

About a year ago, I happened upon this statement about the Monitor in the Harvard Business Review – under the charming heading of “do things that don’t interest you”:

“Many things that end up” being meaningful, writes social scientist Joseph Grenny, “have come from conference workshops, articles, or online videos that began as a chore and ended with an insight. My work in Kenya, for example, was heavily influenced by a Christian Science Monitor article I had forced myself to read 10 years earlier. Sometimes, we call things ‘boring’ simply because they lie outside the box we are currently in.”

If you were to come up with a punchline to a joke about the Monitor, that would probably be it. We’re seen as being global, fair, insightful, and perhaps a bit too earnest. We’re the bran muffin of journalism.

But you know what? We change lives. And I’m going to argue that we change lives precisely because we force open that too-small box that most human beings think they live in.

The Monitor is a peculiar little publication that’s hard for the world to figure out. We’re run by a church, but we’re not only for church members and we’re not about converting people. We’re known as being fair even as the world becomes as polarized as at any time since the newspaper’s founding in 1908.

We have a mission beyond circulation, we want to bridge divides. We’re about kicking down the door of thought everywhere and saying, “You are bigger and more capable than you realize. And we can prove it.”

If you’re looking for bran muffin journalism, you can subscribe to the Monitor for $15. You’ll get the Monitor Weekly magazine, the Monitor Daily email, and unlimited access to CSMonitor.com.

QR Code to US should look inward to tackle opioid crisis, Chinese officials say
Read this article in
https://www.csmonitor.com/World/Asia-Pacific/2017/1228/US-should-look-inward-to-tackle-opioid-crisis-Chinese-officials-say
QR Code to Subscription page
Start your subscription today
https://www.csmonitor.com/subscribe